-

COVID Trial Halted… Not Enough Signed Up
A COVID-related clinical trial was halted. Not for safety. Not for efficacy. Because recruitment failed. So what changed? In this Healthcare Watchdog Investigates episode, we break down: 🚨Why this trial couldn’t find participants 🚨What the enrollment data suggests 🚨The role of FDA requirements, including placebo design 🚨And what it means when clinical trials can’t recruit…
-

Follow the Money: Pharma Bribes EXPOSED? What the Data Shows
What happens when you follow the money in healthcare? This video breaks down a peer-reviewed analysis in the Journal of Law, Medicine & Ethics that examines pharmaceutical industry bribery patterns using OECD global enforcement data. We walk step-by-step through: 👉How financial incentives enter the system 👉The role of intermediaries and third parties 👉Where influence can…
-

Did This Court Ruling Reopen the Pathway to COVID Booster Mandates in Schools?
A new federal court ruling didn’t mandate COVID-19 vaccines for schools—but it may have restored the policy pathway that made mandates possible in the first place. So what actually changed? In this video, we break down: 👉What the court ruled (and what it didn’t) 👉How CDC vaccine guidance influences school requirements 👉Video Clip from Makary…
-

AI Toys for Kids? One Was Pulled After Messages to Children
Many new toys marketed to children now include artificial intelligence technology originally designed for adults. In this video, we examine: ✅ How AI systems are being integrated into children’s toys ✅ Why one AI toy was pulled from sale after messages to children ✅Privacy and surveillance concerns raised by investigators ✅What parents should know before…
-

NYT Reconsiders Marijuana Legalization — Did We Get It Wrong?
Marijuana legalization was widely promoted as a public health and criminal justice reform success. But now, even major media voices — including The New York Times — are revisiting the evidence and questioning whether the risks were underestimated. In this Healthcare Watchdog® investigation, we examine: • What the NYT editorial now says • Rising ER…
-

Gender-Affirming Surgery for Youth: What Evidence Is Missing?
New guidance from a major plastic surgeons’ organization recommends delaying gender-affirming surgical procedures until age 19, citing concerns about the quality and long-term strength of available research. In this Healthcare Watchdog® video, we examine: 🟢✔What the new recommendation actually says 🟢✔How it compares with positions from other U.S. medical organizations 🟢✔The current state of scientific…
-

Hawaii Vaccine Emergency Cuts Doctors and Parents Out of the Process
Federal health agencies say COVID shots for kids should involve shared decision-making — so why did Hawaii just remove it? Hawaii Governor Josh Green’s emergency proclamation allows pharmacists to administer COVID-19 vaccines to children as young as 3 — without a physician’s prescription. Critics say the move bypasses shared decision-making, a standard long emphasized by…
-

All Vaccines Are Still Available: What the CDC Schedule Update Actually Changed
Recent headlines have caused confusion about changes to the CDC childhood immunization schedule. Here’s the key fact that many reports leave out: All vaccines are still available to anyone who wants them. No vaccines were banned, removed from the market, or made illegal. The update affects recommendations and mandates, not availability. Physicians can still prescribe,…
-

California AB 144 EXPOSED: What This Health Bill Really Means for Families
California Assembly Bill 144 is being promoted as a public health measure — but what does it actually do, and who does it affect? In this Healthcare Watchdog® investigation, we break down: 📌What California AB 144 really says 📌Who supported and opposed the bill 📌How it impacts medical choice, families, and healthcare policy 📌What lawmakers…
-

AAP Vaccine Recommendations Under Scrutiny Over Industry Ties
Are conflicts of interest influencing pediatric vaccine policy? The American Academy of Pediatrics (AAP) plays a powerful role in shaping vaccine recommendations that affect millions of children. But financial relationships with pharmaceutical companies raise serious questions about independence, transparency, and trust. In this investigation, Healthcare Watchdog® examines: 📌Financial ties between the AAP and pharmaceutical manufacturers…
